Notice: This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends FLKS vs. MNOV, DERM, SKYE, CNTX, ANRO, BHST, IMUX, AVTX, PYXS, and TNXPShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include MediciNova (MNOV), Journey Medical (DERM), Skye Bioscience (SKYE), Context Therapeutics (CNTX), Alto Neuroscience (ANRO), BioHarvest Sciences (BHST), Immunic (IMUX), Avalo Therapeutics (AVTX), Pyxis Oncology (PYXS), and Tonix Pharmaceuticals (TNXP). These companies are all part of the "medical" sector. Flex Pharma vs. MediciNova Journey Medical Skye Bioscience Context Therapeutics Alto Neuroscience BioHarvest Sciences Immunic Avalo Therapeutics Pyxis Oncology Tonix Pharmaceuticals Flex Pharma (NASDAQ:FLKS) and MediciNova (NASDAQ:MNOV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Does the media prefer FLKS or MNOV? In the previous week, MediciNova had 2 more articles in the media than Flex Pharma. MarketBeat recorded 2 mentions for MediciNova and 0 mentions for Flex Pharma. MediciNova's average media sentiment score of 0.37 beat Flex Pharma's score of 0.00 indicating that MediciNova is being referred to more favorably in the news media. Company Overall Sentiment Flex Pharma Neutral MediciNova Neutral Does the MarketBeat Community prefer FLKS or MNOV? Flex Pharma received 151 more outperform votes than MediciNova when rated by MarketBeat users. Likewise, 73.23% of users gave Flex Pharma an outperform vote while only 48.84% of users gave MediciNova an outperform vote. CompanyUnderperformOutperformFlex PharmaOutperform Votes36173.23% Underperform Votes13226.77% MediciNovaOutperform Votes21048.84% Underperform Votes22051.16% Which has more volatility and risk, FLKS or MNOV? Flex Pharma has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Comparatively, MediciNova has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Do analysts rate FLKS or MNOV? MediciNova has a consensus target price of $9.00, indicating a potential upside of 314.75%. Given MediciNova's stronger consensus rating and higher possible upside, analysts plainly believe MediciNova is more favorable than Flex Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flex Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MediciNova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in FLKS or MNOV? 14.4% of Flex Pharma shares are held by institutional investors. Comparatively, 9.9% of MediciNova shares are held by institutional investors. 7.6% of Flex Pharma shares are held by company insiders. Comparatively, 14.9% of MediciNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has stronger valuation and earnings, FLKS or MNOV? MediciNova has higher revenue and earnings than Flex Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlex Pharma$840K30.33-$21.92MN/AN/AMediciNova$1M106.44-$8.56M-$0.21-10.33 Is FLKS or MNOV more profitable? MediciNova has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. MediciNova's return on equity of -17.55% beat Flex Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Flex Pharma-1,208.42% -98.04% -83.37% MediciNova N/A -17.55%-16.62% SummaryMediciNova beats Flex Pharma on 12 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.48M$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E RatioN/A10.5990.1317.19Price / Sales30.33196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / Book2.765.094.784.78Net Income-$21.92M$151.83M$120.31M$225.60M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$1.41+15.6%N/A+127.4%$25.48M$840,000.000.004MNOVMediciNova2.1575 of 5 stars$2.11+0.5%$9.00+326.5%+46.6%$103.49M$1M-9.9510Analyst ForecastPositive NewsDERMJourney Medical2.5422 of 5 stars$4.91-3.5%$9.38+90.9%N/A$102.57M$79.18M-5.3690SKYESkye Bioscience2.1835 of 5 stars$3.38+0.9%$18.67+452.3%-11.8%$102.54MN/A0.0011News CoveragePositive NewsGap DownCNTXContext Therapeutics2.9747 of 5 stars$1.36-2.2%$6.80+400.0%-8.1%$102.00MN/A-1.477Positive NewsGap DownANROAlto Neuroscience3.2674 of 5 stars$3.75-2.1%$20.00+433.3%N/A$101.14M$210,000.000.00N/AGap UpBHSTBioHarvest SciencesN/A$6.15flat$14.00+127.6%N/A$101.01M$22.43M-4.92N/AAnalyst ForecastHigh Trading VolumeIMUXImmunic2.7773 of 5 stars$1.12-1.3%$11.80+958.3%-28.6%$100.44MN/A-0.9270Positive NewsAVTXAvalo Therapeutics3.7176 of 5 stars$9.65+4.6%N/A-25.8%$100.30M$820,000.000.0040Analyst ForecastNews CoveragePYXSPyxis Oncology2.1368 of 5 stars$1.68+3.7%$10.00+495.2%+1.2%$99.91MN/A-1.5760Analyst ForecastNews CoveragePositive NewsTNXPTonix Pharmaceuticals3.6182 of 5 stars$0.53+120.8%$53.50+9,994.3%-95.0%$99.05M$11.29M0.00103High Trading Volume Related Companies and Tools Related Companies MediciNova Competitors Journey Medical Competitors Skye Bioscience Competitors Context Therapeutics Competitors Alto Neuroscience Competitors BioHarvest Sciences Competitors Immunic Competitors Avalo Therapeutics Competitors Pyxis Oncology Competitors Tonix Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FLKS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
